Pfizer Recalls One Lot Of Neurontin Due To Insufficiently Filled Capsules
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer recalled a single lot of Neurontin (gabapentin) after patients reported that capsules of the epilepsy drug were insufficiently filled